{"denomUnitsSelected":"Participants","description":"The association between the host immune system and response to cabozantinib-s-malate will be assessed in an exploratory manner. each biomarker will be correlated with the clinical outcomes of objective response and progression free survival.","reportingStatus":"NOT_POSTED","timeFrame":"Baseline, day 1 (prior to dose) of cycles 2 and 3","title":"Change in Immune Biomarkers","type":"OTHER_PRE_SPECIFIED"}